Literature DB >> 9129464

Peculiar body composition in patients with Prader-Labhart-Willi syndrome.

P Brambilla1, L Bosio, P Manzoni, A Pietrobelli, L Beccaria, G Chiumello.   

Abstract

Prader-Labhart-Willi syndrome (PWS)-characterized by severe obesity, short stature, hypogonadism, and muscle hypotonia-appears to be an interesting model for body-composition abnormalities. Twenty-seven PWS patients (15 males and 12 females) aged 6-22 y underwent total-body analysis by dual-energy X-ray photon absorptiometry (DXA). For each PWS patient two age- and sex-matched control subjects were studied: one obese subject with a relative body weight (RBW > 120%) and body mass index (BMI) similar to that of the patient and one normal-weight subject (RBW < 120%). Percentage body fat was significantly greater in PWS patients than in obese subjects (47.4 +/- 7.2% compared with 41.9 +/- 9.9%, P < 0.0001) and the same difference was evident for arms and legs but not for the trunk. Lean mass was significantly lower in PWS patients (26.4 +/- 8.2 kg) than in normal-weight subjects (32.9 +/- 10.2 kg) and even more so than in obese subjects (40.3 +/- 13.2 kg) (P < 0.0001). The most affected regions were limbs; thus, the ratio of lean mass in the trunk to that in the limbs was significantly higher in PWS patients (1.19 +/- 0.15) than in obese (1.07 +/- 0.13) and normal-weight (1.07 +/- 0.09) subjects (P < 0.002). The ratio of fat mass to lean mass was significantly higher in PWS patients than in obese subjects (0.90 +/- 0.32 and 0.74 +/- 0.27, P < 0.05). Bone mineral content (BMC) was significantly lower in PWS patients (1503 +/- 46 g) than in normal-weight (1876 +/- 677 g) and obese (2322 +/- 773 g) subjects (P < 0.0001); this difference was most pronounced in the limb region. Bone mineral density (BMD) in PWS patients (0.993 +/- 0.116 g/cm2) did not differ significantly from that of normal-weight subjects (1.033 +/- 0.147 g/cm2) but was significantly lower than that of obese subjects (1.154 +/- 0.139 g/cm2). The influence of age on body composition was assessed by comparing two age subgroups (< 12 y, n = 10; and > or = 12 y, n = 17). The older PWS patients had higher adiposity, lower BMC, and dramatically lower BMD. Also, the lean mass deficit increased with age so that the ratio of fat mass to lean mass was close to 1. In conclusion, PWS patients showed a peculiar body composition, to some extent similar to that found in subjects deficient in growth hormone or even to sedentary and elderly people. These results suggest the importance of an accurate analysis of body composition in PWS patients.

Entities:  

Mesh:

Year:  1997        PMID: 9129464     DOI: 10.1093/ajcn/65.5.1369

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  21 in total

Review 1.  Growth hormone therapy in the Prader-Willi syndrome.

Authors:  W F Paterson; M D C Donaldson
Journal:  Arch Dis Child       Date:  2003-04       Impact factor: 3.791

2.  Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment.

Authors:  T Cadoudal; M Buléon; C Sengenès; G Diene; F Desneulin; C Molinas; S Eddiry; F Conte-Auriol; D Daviaud; P G P Martin; A Bouloumié; J-P Salles; M Tauber; P Valet
Journal:  Int J Obes (Lond)       Date:  2014-01-10       Impact factor: 5.095

3.  Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity?

Authors:  G Bedogni; G Grugni; G Tringali; N Marazzi; A Sartorio
Journal:  J Endocrinol Invest       Date:  2015-04-04       Impact factor: 4.256

4.  Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity.

Authors:  Mariana F Theodoro; Zohreh Talebizadeh; Merlin G Butler
Journal:  Obesity (Silver Spring)       Date:  2006-10       Impact factor: 5.002

5.  Prediction of basal metabolic rate in patients with Prader-Willi syndrome.

Authors:  S Lazzer; G Grugni; G Tringali; A Sartorio
Journal:  Eur J Clin Nutr       Date:  2015-09-23       Impact factor: 4.016

6.  Does the Genetic Cause of Prader-Willi Syndrome Explain the Highly Variable Phenotype?

Authors:  Andreea-Iulia Dobrescu; Adela Chirita-Emandi; Nicoleta Andreescu; Simona Farcas; Maria Puiu
Journal:  Maedica (Bucur)       Date:  2016-09

7.  Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome.

Authors:  L A Gondoni; L Vismara; P Marzullo; R Vettor; A Liuzzi; G Grugni
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

8.  Clinical management of behavioral characteristics of Prader-Willi syndrome.

Authors:  Alan Y Ho; Anastasia Dimitropoulos
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

9.  Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.

Authors:  Aaron L Carrel; Susan E Myers; Barbara Y Whitman; Jens Eickhoff; David B Allen
Journal:  J Clin Endocrinol Metab       Date:  2010-01-08       Impact factor: 5.958

Review 10.  Prader Willi Syndrome: Genetics, Metabolomics, Hormonal Function, and New Approaches to Therapy.

Authors:  Krystal A Irizarry; Mark Miller; Michael Freemark; Andrea M Haqq
Journal:  Adv Pediatr       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.